Long Position on EXAM @ $41.10 on 12/26/2014 (Momentum)

ExamWorks Group, Inc. (EXAM) provides independent medical examinations (IMEs), peer and bill reviews, Medicare compliance, and other related services.

The company operates through four segments: the United States, Canada, the United Kingdom, and Australia.

Its IME services are used by clients to confirm the veracity of claims by sick or injured individuals for workers’ compensation, automotive, personal injury liability, and disability insurance coverage.

The company also offers peer review services, including medical record reviews, nurse file reviews, and utilization reviews by members of its medical panel to provide medical opinion of a claimant’s condition and treatment; bill review services, such as physician and hospital bill reviews, and surgical cost estimates; and other IME related services comprising litigation support, medical record retrieval, administrative support services, and managed technology services.

In addition, it provides Medicare compliance services that comprise Medicare set-asides for worker’s compensation and liability payors. ExamWorks Group, Inc. provides its services through its medical panel of independently contracted, credentialed physicians, and other medical providers.

It serves property and casualty insurance carriers, law firms, third-party claim administrators, government agencies, and state funds. 

Shares have formed a bullish "cup & handle" and higher share prices are expected for this stock.

52-Week Trading Range: $27.79 - $41.34

Entry Point: $41.10

Stop Loss: $39.04

Target Price: $45.20

Updates

1/26/2015 1:46:18 PM

Closing EXAM at $40.90 after its 30 days expired.

Position closed on 1/26/2015 at price of $40.90 with a -0.49% loss in 31 days.

Back to Portfolio